Clinical Trials Logo
  1. Home
  2. Cigarette Smoking
  3. NCT01951456
  4. Details
NCT01951456 Clinical Trial

Resistance Training as an Aid to Smoking Cessation Treatment

Cigarette Smoking Clinical Trial

Official title:
Resistance Training as an Aid to Smoking Cessation Treatment

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01951456
Other study ID # 1R01HL117345-01A1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2013
Est. completion date March 31, 2019

Study information
Verified date April 2018
Source Teachers College, Columbia University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether resistance training can aid smoking cessation.

Recruitment information / eligibility
Status Completed
Enrollment 180
Est. completion date March 31, 2019
Est. primary completion date March 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Age 18 or older, smoke five or more cigarettes a day for at least the past 12 months

Exclusion Criteria:

Participating in any type of exercise for >60 minutes/week over the past 3 months, current smokeless tobacco use, participation in an ongoing effort to quit smoking, current or planned pregnancy, any serious medical condition that would make exercise unsafe

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Resistance training

• Health and Wellness

Locations
Country Name City State
United States Teachers College, Columbia University New York New York

Sponsors (2)
Lead Sponsor Collaborator
Teachers College, Columbia University Brown University

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Smoking cessation Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking). Change from baseline to 3 months
Secondary Cortisol 3, 6, 12 months
Secondary Mood 3, 6, 12 months
Secondary Cigarette cravings 3, 6, 12 months
Secondary Abstinence self-efficacy 3, 6, 12 months
Secondary Sleep 3, 6, 12 months
Secondary Body composition 3, 6, 12 months
Secondary Body weight 3, 6, 12 months
Secondary Lung function 3, 6, 12 months
Secondary Blood pressure 3, 6, 12 months
Secondary Cholesterol profile 3, 6, 12 months
Secondary Glycosylated hemoglobin 3, 6, 12 months
Secondary Muscular strength 3, 6, 12 months
Secondary Aerobic fitness Six-minute walk test 3, 6, 12 months
Secondary Smoking cessation Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking). Change from baseline to 6 months
Secondary Smoking cessation Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking). Change from baseline to 12 months
See also
  Status Clinical Trial Phase
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Active, not recruiting NCT02643914 - Control Systems Approach to Predicting Individualized Dynamics of Nicotine Cravings N/A
Recruiting NCT02422914 - Benefits of Tobacco Free Cigarette N/A
Active, not recruiting NCT02629679 - Sports, Education and Consumption of Substances in Adolescents N/A
Completed NCT02218281 - Developing a Smartphone App With Mindfulness Training for Teen Smoking Cessation N/A
Completed NCT02385227 - Characterization of Biomarkers of Tobacco Exposure, Urge-to-Smoke Following Exclusive and Dual Ad Lib Use of Electronic Cigarettes N/A
Completed NCT01199380 - Behavioral Activation Intervention for Smoking Cessation in Smokers With Depressive Symptoms Phase 2
Completed NCT01692353 - Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers N/A
Completed NCT01081119 - Brief Voluntary Alcohol and Drug Intervention for Middle School Youth Phase 2
Completed NCT00756704 - The Effectiveness of Smoking Cessation Guidelines in the Emergency Department N/A
Completed NCT00802919 - Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors Phase 4
Completed NCT00682474 - School Nurse-Delivered Smoking Cessation Intervention Phase 2/Phase 3
Completed NCT05520775 - Semaglutide for Alcohol Use Disorder Phase 2
Completed NCT03743532 - E-Cigarettes and Financial Incentives to Promote Tobacco Harm Reduction Among Adults Accessing Shelter Services N/A
Terminated NCT03840694 - Nicotine Withdrawal and Reward Processing: Connecting Neurobiology to Real-world Behavior N/A
Completed NCT06032793 - Effects of Deep Breathing Exercise on Pulmonary Function, Perceived Stress and Physical Fitness. N/A
Terminated NCT03326128 - High Dose Bupropion for Smoking Cessation - Pilot Study Phase 2
Recruiting NCT03218670 - Your Health in On Click N/A
Completed NCT02538042 - Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue) N/A